(Total Views: 672)
Posted On: 08/10/2019 6:31:11 PM
Post# of 145250
I have wondered that myself. My guess is they did not originally track this data, but maybe they began more recently once they learned of the CCR5 / cancer link. It would be interesting to compare leronlimab HIV patients to non-leronlimab patients cancer rates to see the difference.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.